ArticleCancer biomarkers : section A of Disease markers2020

Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma.

Wen-Lung Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.